Advances in systemic therapy for advanced pancreatobiliary malignancies

Thorvardur R. Halfdanarson; Sigurdis Haraldsdottir; Mitesh J. Borad

doi:10.12688/f1000research.2-105.v1

Advances in systemic therapy for advanced pancreatobiliary malignancies

Thorvardur R. Halfdanarson, Sigurdis Haraldsdottir, Mitesh J. Borad

Research output: Contribution to journal › Article › peer-review

Abstract

Pancreatobiliary malignancies are relatively uncommon and the overall prognosis is poor. Treatment options for advanced disease are limited to systemic therapy for metastatic disease and a combination of systemic therapy and radiation therapy for locally advanced but unresectable tumors. There have been significant advances in the treatment of pancreatobiliary cancers in recent years but the prognosis for patient survival remains disappointingly poor. We review the current treatment options for locally advanced pancreatobiliary malignancies and highlight recent advances in systemic therapy, including novel approaches using targeted treatments.

Original language	English (US)
Article number	2-105.v1
Journal	F1000Research
Volume	2
DOIs	https://doi.org/10.12688/f1000research.2-105.v1
State	Published - Apr 8 2013

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology
General Immunology and Microbiology
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.12688/f1000research.2-105.v1

Cite this

@article{ab81c43127c8431d9c2f566982688244,

title = "Advances in systemic therapy for advanced pancreatobiliary malignancies",

abstract = "Pancreatobiliary malignancies are relatively uncommon and the overall prognosis is poor. Treatment options for advanced disease are limited to systemic therapy for metastatic disease and a combination of systemic therapy and radiation therapy for locally advanced but unresectable tumors. There have been significant advances in the treatment of pancreatobiliary cancers in recent years but the prognosis for patient survival remains disappointingly poor. We review the current treatment options for locally advanced pancreatobiliary malignancies and highlight recent advances in systemic therapy, including novel approaches using targeted treatments.",

author = "Halfdanarson, {Thorvardur R.} and Sigurdis Haraldsdottir and Borad, {Mitesh J.}",

year = "2013",

month = apr,

day = "8",

doi = "10.12688/f1000research.2-105.v1",

language = "English (US)",

volume = "2",

journal = "F1000Research",

issn = "2046-1402",

publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Advances in systemic therapy for advanced pancreatobiliary malignancies

AU - Halfdanarson, Thorvardur R.

AU - Haraldsdottir, Sigurdis

AU - Borad, Mitesh J.

PY - 2013/4/8

Y1 - 2013/4/8

N2 - Pancreatobiliary malignancies are relatively uncommon and the overall prognosis is poor. Treatment options for advanced disease are limited to systemic therapy for metastatic disease and a combination of systemic therapy and radiation therapy for locally advanced but unresectable tumors. There have been significant advances in the treatment of pancreatobiliary cancers in recent years but the prognosis for patient survival remains disappointingly poor. We review the current treatment options for locally advanced pancreatobiliary malignancies and highlight recent advances in systemic therapy, including novel approaches using targeted treatments.

AB - Pancreatobiliary malignancies are relatively uncommon and the overall prognosis is poor. Treatment options for advanced disease are limited to systemic therapy for metastatic disease and a combination of systemic therapy and radiation therapy for locally advanced but unresectable tumors. There have been significant advances in the treatment of pancreatobiliary cancers in recent years but the prognosis for patient survival remains disappointingly poor. We review the current treatment options for locally advanced pancreatobiliary malignancies and highlight recent advances in systemic therapy, including novel approaches using targeted treatments.

UR - http://www.scopus.com/inward/record.url?scp=84914812678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84914812678&partnerID=8YFLogxK

U2 - 10.12688/f1000research.2-105.v1

DO - 10.12688/f1000research.2-105.v1

M3 - Article

SN - 2046-1402

VL - 2

JO - F1000Research

JF - F1000Research

M1 - 2-105.v1

ER -

Advances in systemic therapy for advanced pancreatobiliary malignancies

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this